Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
Completed · Phase 2
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of peripheral stem cell transplantation following chemotherapy in treating patients with acute myeloid leukemia in second remission.
Key facts
- Study ID
- NCT00002768
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 51
- Starts
- 1996-06-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2016-06-28
Who can join
Age: 15 and older, up to 69. Sex: any. Healthy volunteers: not accepted.
Where it is running
- UCSF Cancer Center and Cancer Research Institute — San Francisco, California, United States
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland — Baltimore, Maryland, United States
- St. Joseph's Hospital and Medical Center — Paterson, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.